Stock Screener App

무료 - Play StoreApp Store

설치하다 설치하다

WGS

$64.097.20%-4.97

Genedx Holdings Corp (WGS)

Date: O: H: L: C: Vol:

Genedx Holdings Corp 주식(WGS)의 최신 뉴스

Encompass Health Expands Rehab Footprint With New Maine Hospital - Zacks Investment Research

GeneDx Holdings (NasdaqGS:WGS) Stock Forecast & Analyst Predictions - Simply Wall Street

GeneDx CEO Katherine Stueland sells $1.03m in stock - Investing.com

GeneDx Director Thomas Fuchs Reports RSU Conversion to 1,146 Shares - Kalkine Media

GeneDx (WGS) CEO sells 10,501 shares to cover taxes - Stock Titan

Tax-driven stock sale by GeneDx (WGS) CFO after RSU vesting - Stock Titan

GeneDx Holdings (WGS) director receives 1,146 shares at no cash cost - Stock Titan

GeneDx (WGS) CEO sells shares in tax-withholding trade - Stock Titan

GeneDx (WGS) CFO sells stock for taxes, holds 41,476 shares - Stock Titan

WGS: GeneDx Holdings Corp Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C - Yahoo Finance

GeneDx at Wells Fargo healthcare conference: growth and collections in focus - Investing.com Canada

GeneDx at Wells Fargo healthcare conference: growth and collections in focus - Investing.com UK

GeneDx Holdings CFO Kevin Feeley Executes 717 Shares at $0 and Sells at $83.84 on Sept. 1, 2026 - Kalkine Media

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Reach Out - ACCESS Newswire

GeneDx Holdings (WGS) CFO sells shares in tax-cover trade - Stock Titan

GeneDx CFO Kevin Feeley Discloses RSU Vesting and Tax Withholding Stock Sale - Kalkine Media

Insider at GeneDx (NASDAQ: WGS) lines up new stock sale after June tax trades - Stock Titan

Planned $1.2M insider sale at GeneDx (NASDAQ: WGS) tied to 2026 RSU vesting - Stock Titan

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm - Eastern Progress

GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree - marketscreener.com

WGS Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against GeneDx Holdings Corp - Eastern Progress

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics Acquisition - HBSS - Eastern Progress

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit - Eastern Progress

WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm - Eastern Progress

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect - ACCESS Newswire

GeneDx Holdings (WGS) Study Data Puts Its Fair Value Debate Back In Focus - Sahm

A GeneDx study found genetic diagnoses in 63% of children with faltering growth - Stock Titan

A Look at GeneDx Holdings Corp (WGS) After 5.5% Gain -- GF Value $73.66 vs Price $87.06 - GuruFocus

GeneDx Holdings Corp. $WGS Shares Purchased by Bank of America Corp DE - MarketBeat

Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates? - Yahoo Finance

Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Cor - The National Law Review

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

2026-08-18 | GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:WGS | Press Release - Stockhouse

GeneDx: Why I Think The Worst Is Behind The Business (NASDAQ:WGS) - Seeking Alpha

WGS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Inv - The National Law Review

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect - ACCESS Newswire

WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review

GeneDx Holdings (WGS) Slips 1.35% to $78.08, Holds Midpoint of Trading Range - Call Flow Alert - Vinanet

GeneDx Holdings (WGS) Slips 1.35% as Shares Hold Between Key Support and Resistance - Delta Hedging - Vinanet

GeneDx Holdings (WGS), Why Is This Fresh Development Drawing Attention? - Sahm

Precision Trading with Genedx Holdings Corp. (WGS) Risk Zones - Stock Traders Daily

The Manufacturers Life Insurance Company Sells 12,820 Shares of GeneDx Holdings Corp. $WGS - MarketBeat

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect - ACCESS Newswire

Sei Investments Co. Trims Stock Position in GeneDx Holdings Corp. $WGS - MarketBeat

WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review

Is GeneDx Holdings Corp (WGS) Overvalued After 5.1% Rally? GF Va - GuruFocus

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Goldman Sachs Group (WGS) discloses 5.8% beneficial stake in GeneDx Class A - Stock Titan

WGS와(과) 유사한 종목

PSNL$15.760.38%

FRNM$11.616.97%

CSTL$34.945.97%